Anne-Marie Koop

302 27. Rosenzweig EB, Abman SH, Adatia I, Beghetti M, Bonnet D, Haworth S, Ivy DD, Berger RMF. Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management. Eur Respir J 2019;53. 28. Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Krishna Kumar R, Landzberg M, Machado RF, Olschewski H, Robbins IM, Souza R. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013;62. 29. Koestenberger M, Ravekes W, Everett AD, Stueger HP, Heinzl B, Gamillscheg A, Cvirn G, Boysen A, Fandl A, Nagel B. Right Ventricular Function in Infants, Children andAdolescents: Reference Values of the Tricuspid Annular Plane Systolic Excursion (TAPSE) in 640 Healthy Patients and Calculation of z Score Values. J Am Soc Echocardiogr 2009; 22 :715–719. 30. Rossi MA, Carillo S V. Cardiac hypertrophy due to pressure and volume overload: distinctly different biological phenomena? Int J Cardiol 1991;31:133–141. 31. Grossman W. Cardiac hypertrophy: Useful adaptation or pathologic process? Am J Med 1980;69:576–584. 32. Hirono K, Sekine M, Shiba N, Hayashi S, Nakaoka H, Ibuki K, Saito K, Watanabe K, Ozawa S, Higuma T, Yoshimura N, Kitajima I, Ichida F. N-terminal pro-Brain Natriuretic Peptide as a Predictor of Reoperation in Children With Surgically Corrected Tetralogy of Fallot. Circ J 2013;78:693–700. 33. Berg J van den, Strengers JLM, Wielopolski PA, Hop WC, Meijboom FJ, Rijke YB de, Boomsma F, Bogers AJJC, Pattynama PMT, Helbing WA. Assessment of biventricular functional reserve and NT-proBNP levels in patients with RV volume overload after repair of tetralogy of Fallot at young age. Int J Cardiol Elsevier Ireland Ltd; 2009;133:364–370. 34. Baggen VJM, Baart SJ, Bosch AE van den, Eindhoven JA, Witsenburg M, Cuypers JAAE, Roos‐ Hesselink JW, Boersma E. Prognostic Value of Serial N‐ Terminal Pro‐ B‐ Type Natriuretic Peptide Measurements in Adults With Congenital Heart Disease. J Am Heart Assoc 2018; 7 . 35. Lai CTM, Wong SJ, Ip JJK, Wong WK, Tsang KC, Lam WWM, Cheung YF. Plasma Levels of High Sensitivity Cardiac Troponin T in Adults with Repaired Tetralogy of Fallot. Sci Rep Nature Publishing Group; 2015;5:1–8. 36. Dupuis J, Cernacek P, Tardif JC, Stewart DJ, Gosselin G, Dyrda I, Bonan R, Crepeau J. Reduced pulmonary clearance of endothelin-1 in pulmonary hypertension. Am Heart J 1998;135:614–620. 37. Stangl K, DschietzigT, Richter C, LauleM, StanglV, Tanis E, Baumann G, Felix SB. Pulmonary release and coronary and peripheral consumption of big endothelin and endothelin-1 in severe heart failure: acute effects of vasodilator therapy. Circulation 2000;102:1132–1138. 38. Meyer SL, Wolff D, Ridderbos FS, Eshuis G, Hillege H, Willems TP, Ebels T, Melle JP van, Berger RMF. GDF‐ 15 (Growth Differentiation Factor 15) Is Associated With Hospitalization and Mortality in Patients With a Fontan Circulation. J Am Heart Assoc 2020;15. 39. Eindhoven JA, Bosch AE Van Den, Jansen PR, Boersma E, Roos-Hesselink JW. The Usefulness of brain natriuretic peptide in complex congenital heart disease: A systematic review. J Am Coll Cardiol Elsevier Inc.; 2012;60:2140–2149. 40. Gan CT, McCann GP, Marcus JT, Wolferen SA van, Twisk JW, Boonstra A, Postmus PE, Vonk-Noordegraaf A. NT-proBNP reflects right ventricular structure and function in pulmonary hypertension. Eur Respir J 2006;28:1190–1194. 41. Norozi K, Buchhorn R, Kaiser C, Hess G, Grunewald RW, Binder L, Wessel A. Plasma